Aims and Scope of Experimental Hematology
Experimental Hematology is a peer-reviewed medical journal of hematology, which publishes original research articles and reviews, as well as the abstracts of the annual proceedings of the Society for Hematology and Stem Cells (formerly known as the International Society for Experimental Hematology). The journal is published monthly by Elsevier, and the annual proceedings are published in a supplement issue. The journal is edited by Connie J. Eaves. Less
Key Metrics
CiteScore 

5.5
H-Index 

126
Impact Factor 

< 5
SJR 

Q1Genetics

SNIP 

0.7
Recommended pre-submission checks
Powered by 

Topics Covered on Experimental Hematology
Experimental Hematology Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1973 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Experimental Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Experimental Hematology
CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances.
- 1 Aug 2026
- Experimental hematology
Inhibition of activated protein C anticoagulant function enhances coagulation but does not interrupt downstream mechanisms driving hemophilic arthropathy.
- 1 Jul 2026
- Experimental hematology
A function-first legacy in hematopoietic stem cell biology: the scientific impact of Hal E. Broxmeyer.
- 1 Jul 2026
- Experimental hematology
MYC unchained: dosage-dependent locking of the myeloid fate (or not).
- 1 Jul 2026
- Experimental hematology
Stem11 score: toward rapid clinical prognostication for acute myeloid leukemia.
- 1 Jul 2026
- Experimental hematology
Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALL.
- 23 Jun 2026
- Experimental hematology
CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances.
- 1 Aug 2026
- Experimental hematology
Inhibition of activated protein C anticoagulant function enhances coagulation but does not interrupt downstream mechanisms driving hemophilic arthropathy.
- 1 Jul 2026
- Experimental hematology
A function-first legacy in hematopoietic stem cell biology: the scientific impact of Hal E. Broxmeyer.
- 1 Jul 2026
- Experimental hematology
MYC unchained: dosage-dependent locking of the myeloid fate (or not).
- 1 Jul 2026
- Experimental hematology
Stem11 score: toward rapid clinical prognostication for acute myeloid leukemia.
- 1 Jul 2026
- Experimental hematology
Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALL.
- 23 Jun 2026
- Experimental hematology